Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Way to Treat Broken Ribs

By HospiMedica staff writers
Posted on 15 Aug 2006
A new surgical technique and a new device are helping to smooth the progress of repair and facilitate pain relief and healing in people with debilitating rib fractures.

Surgeons in the Oregon Health & Science University (OHSU, Portland, OR, USA) trauma/critical care program are challenging the decades-old practice of not fixing rib fractures. More...
In a first-of-its kind pilot study, the surgeons hope to identify people most at risk of prolonged pain and disability from broken ribs. To be eligible for the rib fracture surgical repair study, participants must be 16 or older and have a rib fracture confirmed by x-ray or a computerized tomography (CT) scan within 10 days of injury, and be registered at OHSU.

Participants will be surveyed over a period of six months to measure their overall health; the dosage, frequency, and identification of pain medications; and whether they've returned to work, with or without restrictions. The researchers hope to identify subsets of people who respond better to surgical repair than nonsurgical therapy and to develop standard criteria for treatment.

"Historically, physicians have been taught that nothing can be done to fix a rib fracture,” said John Mayberry, M.D., principal investigator of the study and associate professor of surgery in the OHSU School of Medicine. "Based on findings from our previous research, we are convinced that current, traditional nonsurgical management of rib fractures does not facilitate pain relief or a speedy return to normal activity. We believe new strategies, including a minimally invasive surgical method we've developed, will alleviate pain and reduce disability for individual participants.”

The researchers have invented a new rib fracture plating system, known as a U-plate, which could better facilitate rib healing. Once implanted, the U-plate, which is made of titanium and resembles a U-shaped hook, bridges the fracture, which helps promote and expedite healing, and helps prevent further injury. The U-plate has been approved by the U.S. Food and Drug Administration (FDA), and is distributed by Acute Innovations (Hillsboro, OR, USA).



Related Links:
Oregon Health & Science University

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.